Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial.
Malekzadeh R, Abedini A, Mohsenpour B, Sharifipour E, Ghasemian R, Javad-Mousavi SA, Khodashahi R, Darban M, Kalantari S, Abdollahi N, Salehi MR, Rezaei Hosseinabadi A, Khorvash F, Valizadeh M, Dastan F, Yousefian S, Hosseini H, Anjidani N, Tabarsi P.
Malekzadeh R, et al. Among authors: javad mousavi sa.
Int Immunopharmacol. 2020 Dec;89(Pt B):107102. doi: 10.1016/j.intimp.2020.107102. Epub 2020 Oct 13.
Int Immunopharmacol. 2020.
PMID: 33075713
Free PMC article.
Clinical Trial.